Thomas Trimarchi
CFO, President at BridgeBio Pharma, Inc. (BBIO)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.0M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 10,456362,389 held (−3%) | $64.82 | $678K | +0.8% |
| May 19SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 3,195359,194 held (−1%) | $65.95 | $211K | -0.9% |
| Feb 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 13,400336,785 held (−4%) | $74.71 | $1.0M | -12.5% |
| Feb 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 200336,585 held (−0%) | $75.38 | $15K | -13.3% |
| Nov 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 9,978389,786 held (−2%) | $66.19 | $660K | -1.3% |
| Nov 18SEC | BBIOBridgeBio Pharma, Inc. | Sell Plan | 6,956382,830 held (−2%) | $66.84 | $465K | -2.2% |
- Sell
CFO, President Thomas Trimarchi sold $678K of BBIO at $64.82 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Thomas Trimarchi sold $211K of BBIO at $65.95 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Thomas Trimarchi sold $1.0M of BBIO at $74.71 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Thomas Trimarchi sold $15K of BBIO at $75.38 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Thomas Trimarchi sold $660K of BBIO at $66.19 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO, President Thomas Trimarchi sold $465K of BBIO at $66.84 — pre-scheduled 10b5-1 plan sale.